Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Li, Feng  [Clear All Filters]
2024
Chen Y, Qiang Y, Fan J, Zheng Q, Yan L, Fan G, Song X, Zhang N, Lv Q, Xiong J, et al. Aggresome formation promotes ASK1/JNK signaling activation and stemness maintenance in ovarian cancer. Nat Commun. 2024;15(1):1321.
Zhang K, Hu W, Li F, Wen C, Zhou L, Zhang L, Lian J, Liu S, Wang S, Zhang Y. IL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells. Br J Cancer. 2024.
Li F, Wang H, Ye T, Guo P, Lin X, Hu Y, Wei W, Wang S, Ma G. Recent Advances in Material Technology for Leukaemia Treatments. Adv Mater. 2024:e2313955.
Li F, Yu H, Qi A, Zhang T, Huo Y, Tu Q, Qi C, Wu H, Wang X, Zhou J, et al. Regulatory Non-Coding RNAs during Porcine Viral Infections: Potential Targets for Antiviral Therapy. Viruses. 2024;16(1).
Ma S, Xue R, Zhu H, Han Y, Ji X, Zhang C, Wei N, Xu J, Li F. Selenomethionine preconditioned mesenchymal stem cells derived extracellular vesicles exert enhanced therapeutic efficacy in intervertebral disc degeneration. Int Immunopharmacol. 2024;132:112028.
2023
Meraz IM, Majidi M, Fang B, Meng F, Gao L, Shao RP, Song R, Li F, Lissanu Y, Chen H, et al. 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. Commun Biol. 2023;6(1):509.
Meraz IM, Majidi M, Fang B, Meng F, Gao L, Shao RP, Song R, Li F, Lissanu Y, Chen H, et al. Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib. Commun Biol. 2023;6(1):608.
Qi W, Li F, Wang G, Yan Y, Tian J, Wang T, Wang Z, Zhang Y. The effects of mesenchymal stem cells-derived exosomes in rheumatoid arthritis: a review. Clin Exp Rheumatol. 2023.
Yang K, Xie Y, Xue L, Li F, Luo C, Liang W, Zhang H, Li Y, Ren Y, Zhao M, et al. M2 tumor-associated macrophage mediates the maintenance of stemness to promote cisplatin resistance by secreting TGF-β1 in esophageal squamous cell carcinoma. J Transl Med. 2023;21(1):26.
Sun J, Osenberg S, Irwin A, Ma L-H, Lee N, Xiang Y, Li F, Wan Y-W, Park I-H, Maletic-Savatic M, et al. Mutations in the transcriptional regulator MeCP2 severely impact key cellular and molecular signatures of human astrocytes during maturation. Cell Rep. 2023;42(1):111942.
Yu H, Liu B, Zhang Y, Gao X, Wang Q, Xiang H, Peng X, Xie C, Wang Y, Hu P, et al. Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants. Nat Commun. 2023;14(1):1058.
Huang H, Li J, Wang C, Xing L, Cao H, Wang C, Leung CYan, Li Z, Xi Y, Tian H, et al. Using Decellularized Magnetic Microrobots to Deliver Functional Cells for Cartilage Regeneration. Small. 2023:e2304088.
2022
Zhou Q, Meng D, Li F, Zhang X, Liu L, Zhu Y, Liu S, Xu M, Deng J, Lei Z, et al. Inhibition of HIPK2 protects stress-induced pathological cardiac remodeling. EBioMedicine. 2022;85:104274.
Kogiso M, Qi L, Du Y, Braun FK, Zhang H, L Huang F, Guo L, Huang Y, Teo W-Y, Lindsay H, et al. Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma. Transl Oncol. 2022;18:101368.
2021
Feng X, Huang Y-L, Zhang Z, Wang N, Yao Q, Pang L-J, Li F, Qi Y. The role of SYT-SSX fusion gene in tumorigenesis of synovial sarcoma. Pathol Res Pract. 2021;222:153416.
2020
Yuan H, Guo H, Luan X, He M, Li F, Burnett J, Truchan N, Sun D. Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer. Mol Pharm. 2020.
Zhang Z, Li F, Tian Y, Cao L, Gao Q, Zhang C, Zhang K, Shen C, Ping Y, Maimela NResegofets, et al. Metformin Enhances the Antitumor Activity of CD8 T Lymphocytes via the AMPK-miR-107-Eomes-PD-1 Pathway. J Immunol. 2020.
Yao C, Wu W, Tang H, Jia X, Tang J, Ruan X, Li F, Leong DTai, Luo D, Yang D. Self-assembly of stem cell membrane-camouflaged nanocomplex for microRNA-mediated repair of myocardial infarction injury. Biomaterials. 2020;257:120256.
2019
Li F, Jin D, Guan L, Zhang C-C, Wu T, Wang Y-J, Gao D-S. CEP55 promoted the migration, invasion and neuroshpere formation of the glioma cell line U251. Neurosci Lett. 2019.
Li F, Yuan CW, Xu S, Zu T, Woappi Y, Lee CAA, Abarzua P, Wells M, Ramsey MR, Frank NY, et al. Loss of the Epigenetic Mark, 5-hmC, in Psoriasis: Implications for Epidermal Stem Cell Dysregulation. J Invest Dermatol. 2019.
Liu Y, Zeng R, Wang Y, Huang W, Hu B, Zhu G, Zhang R, Li F, Han J, Li Y. Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6. Brain Res. 2019:146422.
Sun W, Dai L, Yu H, Puspita B, Zhao T, Li F, Tan JL, Lim YTing, Chen MWei, Sobota RM, et al. Monitoring structural modulation of redox-sensitive proteins in cells with MS-CETSA. Redox Biol. 2019;24:101168.
Tan JL, Li F, Yeo JZ, Yong KJia, Bassal MA, Ng GHao, Lee MYin, Leong CYan, Tan HKee, Wu C-S, et al. New High-throughput Screen Identifies Compounds That Reduce Viability Specifically In Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation. Gastroenterology. 2019.
Li F, Ge Y, Liu D, Songyang Z. The role of telomere-binding modulators in pluripotent stem cells. Protein Cell. 2019.
2015
Zhou Y, Wang Y, Ju X, Lan J, Zou H, Li S, Qi Y, Jia W, Hu J, Liang W, et al. Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis. Biomark Med. 2015:1-14.

Pages